NuviaLab Limited – Trademark Portfolio

Entity Type: 99

NuviaLab Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include NUVIALAB, MEMBER XXL, and PROFLEXEN FOOD SUPPLEMENT. The owner is based in Limassol.

Kimonos 40

Limassol CY-3095 , CY

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NuviaLab Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does NuviaLab Limited have?

NuviaLab Limited has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does NuviaLab Limited file in?

NuviaLab Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are NuviaLab Limited's most well-known trademarks?

NuviaLab Limited's registered trademark portfolio includes well-known marks such as NUVIALAB, MEMBER XXL, and PROFLEXEN FOOD SUPPLEMENT. These are among 3 currently registered trademarks in the portfolio.

What is NuviaLab Limited's trademark registration success rate?

NuviaLab Limited has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.